EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseUmbrella ReviewOpen Access · CC BY 4.0

Effects of turmeric (Curcuma longa) supplementation on glucose metabolism in diabetes mellitus and metabolic syndrome: An umbrella review and updated meta-analysis

Thanika Pathomwichaiwat iD, Peerawat Jinatongthai iD, Napattaoon Prommasut, Kanyarat Ampornwong, Wipharak Rattanavipanon iD, Surakit Nathisuwan, Ammarin Thakkinstian

PLOS ONE · 20.07.2023 · 18 (7) · e0288997

DOI: 10.1371/journal.pone.0288997 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS ONE, online erschienen am 20.07.2023. Verfasst von Thanika Pathomwichaiwat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Pharmaceutical Botany, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metabolic Syndrome, Prediabetic State. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aims to comprehensively review the existing evidence and conduct analysis of updated randomized controlled trials (RCTs) of turmeric ( Curcuma longa , CL) and its related bioactive compounds on glycemic and metabolic parameters in patients with type 2 diabetes (T2DM), prediabetes, and metabolic syndrome (MetS) together with a sub-group analysis of different CL preparation forms.

Methods

An umbrella review (UR) and updated systematic reviews and meta-analyses (SRMAs) were conducted to evaluate the effects of CL compared with a placebo/standard treatment in adult T2DM, prediabetes, and MetS. The MEDLINE, Embase, The Cochrane Central Register of Control Trials, and Scopus databases were searched from inception to September 2022. The primary efficacy outcomes were hemoglobin A1C (HbA1C) and fasting blood glucose (FBG). The corrected covered area (CCA) was used to assess overlap. Mean differences were pooled across individual RCTs using a random-effects model. Subgroup and sensitivity analyses were performed for various CL preparation forms.

Results

Fourteen SRMAs of 61 individual RCTs were included in the UR. The updated SRMA included 28 studies. The CCA was 11.54%, indicating high overlap across SRMAs. The updated SRMA revealed significant reduction in FBG and HbA1C with CL supplementation, obtaining a mean difference (95% confidence interval [CI]) of –8.129 (–12.175, –4.084) mg/dL and –0.134 (–0.304, –0.037) %, respectively. FBG and HbA1C levels decreased with all CL preparation forms as did other metabolic parameters levels. The results of the sensitivity and subgroup analyses were consistent with those of the main analysis.

Conclusion

CL supplementation can significantly reduce FBG and HbA1C levels and other metabolic parameters in T2DM and mitigate related conditions, including prediabetes and MetS.

Trial registration

PROSPERO ( CRD42016042131 ).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Metabolic SyndromePrediabetic StateAdultHumansBlood GlucoseCurcumaDietary SupplementsGlycated HemoglobinRandomized Controlled Trials as TopicMeta-Analysis as TopicSystematic Reviews as Topic

Substanzen

Blood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • Faculty of Pharmacy, Department of Pharmaceutical Botany, Mahidol University, Bangkok, Thailand.
  • Faculty of Pharmaceutical Sciences, Pharmacy Practice Division, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
  • Faculty of Pharmacy, Department of Pharmacy, Mahidol University, Bangkok, Thailand.
  • Faculty of Medicine Ramathibodi Hospital, Department of Clinical Epidemiology and Biostatistics, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Thanika Pathomwichaiwat, Peerawat Jinatongthai, Wipharak Rattanavipanon

Förderung

  • National Research Council of Thailand

Zitieren

APA

Pathomwichaiwat, T., Jinatongthai, P., Prommasut, N., Ampornwong, K., Rattanavipanon, W., Nathisuwan, S., & Thakkinstian, A. (2023). Effects of turmeric (Curcuma longa) supplementation on glucose metabolism in diabetes mellitus and metabolic syndrome: An umbrella review and updated meta-analysis. PLOS ONE, 18(7), e0288997. https://doi.org/10.1371/journal.pone.0288997

Vancouver

Pathomwichaiwat T, Jinatongthai P, Prommasut N, Ampornwong K, Rattanavipanon W, Nathisuwan S, et al. Effects of turmeric (Curcuma longa) supplementation on glucose metabolism in diabetes mellitus and metabolic syndrome: An umbrella review and updated meta-analysis. PLOS ONE. 2023;18(7):e0288997. doi:10.1371/journal.pone.0288997

BibTeX
@article{Pathomwichaiwat2023,
  author = {Pathomwichaiwat, Thanika and Jinatongthai, Peerawat and Prommasut, Napattaoon and Ampornwong, Kanyarat and Rattanavipanon, Wipharak and Nathisuwan, Surakit and Thakkinstian, Ammarin},
  title = {Effects of turmeric (Curcuma longa) supplementation on glucose metabolism in diabetes mellitus and metabolic syndrome: An umbrella review and updated meta-analysis},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {7},
  pages = {e0288997},
  doi = {10.1371/journal.pone.0288997}
}
Kostenlos starten →